Pulmonx Co (NASDAQ:LUNG) Given Consensus Recommendation of Moderate Buy by Brokerages wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target […]
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Pulmonx (NASDAQ:LUNG – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.36) EPS for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.07, Zacks reports. Pulmonx had a negative net margin of 80.46% and a negative return on equity of 46.61%. The firm had revenue of $18.85 million for […]